Jared Schwartz, MD, PhD
Jared Schwartz has over 30 years of pathology expertise, and currently serves as CMO of Aperio. Prior to Aperio, Dr. Schwartz was President of the College of American Pathologists, and Director of Pathology and Laboratory Medicine at Presbyterian Healthcare in Charlotte, North Carolina. Board certified in anatomic and clinical pathology with subspecialty boards in medical microbiology and cytopathology, he is a graduate of Duke University Medical School, where he completed his residency and fellowship training, and served as chief resident. He was appointed to the Clinical Laboratory Improvement Advisory Committee by HHS, and was a co-chair and author of the ASCO/CAP Guidelines on HER2, which was published in the January 2007 editions of the Journal of Clinical Oncology and Archives of Pathology and Laboratory Medicine. He is one of the authors of the ASCO/CAP Guidelines on ER/PR, which was published in both journals in April 2010.